Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Rafael M BitencourtReinaldo N Takahashi

Abstract

The present study investigated the central effects of the eCB uptake/metabolism inhibitor AM404 and the phytocannabinoid cannabidiol (CBD) on the extinction of contextual fear memories in rats. Rats were conditioned and 24 h later subjected to three consecutive 9-min non-reinforced exposures to the conditioning context (extinction sessions, 24 h intervals). AM404 or CBD was injected i.c.v. 5 min before each extinction session and a 3-min drug-free test of contextual memory was performed 24 h after the last extinction session. AM404 (1.0 microg/microl, i.c.v.) and CBD (2.0 microg/microl, i.c.v.) facilitated extinction of contextual fear memory, with persistent effects. These responses were antagonized by the CB1-selective antagonist SR141716A (0.2 mg/kg, i.p.), but not by the TRPV1-selective antagonist capsazepine (5.0 microg/microl, i.c.v.). The effect of the anxiolytic drug Diazepam (DZP) on the extinction of contextual fear memory was also investigated. In contrast with the CBD and AM404 results, DZP induced a general reduction in the expression of conditioned freezing. Both AM404 and CBD induced anti-anxiogenic effect in the fear-potentiated plus-maze test, whereas DZP was anxiolytic in conditioned and unconditioned rats. In...Continue Reading

References

Jan 1, 1990·Psychopharmacology·F S GuimarãesA W Zuardi
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M HerkenhamK C Rice
Aug 1, 1973·The Journal of Pharmacy and Pharmacology·E A CarliniA C Berardi
Aug 7, 1970·Science·R MechoulamY Grunfeld
Mar 1, 1969·Journal of Comparative and Physiological Psychology·R J Blanchard, D C Blanchard
Sep 1, 1994·Pharmacology, Biochemistry, and Behavior·A P CruzF G Graeff
May 24, 2000·European Journal of Pharmacology·P M ZygmuntE D Högestätt
Dec 7, 2000·Chemistry and Physics of Lipids·R Mechoulam, L Hanus
May 23, 2002·The Journal of Pharmacology and Experimental Therapeutics·S A Varvel, Aron H Lichtman
Jun 8, 2002·Science·Ellen E PaxinosRobert C Fleischer
Oct 24, 2002·British Journal of Anaesthesia·L PainP Oberling
Nov 5, 2002·Journal of Clinical Pharmacology·Raphael MechoulamRuth Gallily
Dec 4, 2002·Nature Medicine·Satish KathuriaDaniele Piomelli
Feb 26, 2003·European Journal of Pharmacology·S Mechiel Korte, Sietse F De Boer
Jul 5, 2003·Physiological Reviews·Tamas F FreundDaniele Piomelli
Oct 30, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·José Alexandre de Souza CrippaGeraldo Filho Busatto
Apr 14, 2004·The European Journal of Neuroscience·J HallerT F Freund
May 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·D FegleyD Piomelli
May 18, 2004·European Journal of Pharmacology·Christopher J FowlerVincenzo Di Marzo
May 21, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Akinobu SuzukiSatoshi Kida
Nov 24, 2004·Neuroscience and Biobehavioral Reviews·J W RudyP Matus-Amat
Dec 25, 2004·Psychopharmacology·S A VarvelA H Lichtman
Jan 8, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jasmeer P ChhatwalKerry J Ressler
Mar 3, 2005·European Journal of Pharmacology·Sabine M HölterCarsten T Wotjak
Mar 25, 2005·The European Journal of Neuroscience·Sachin PatelCecilia J Hillard
Apr 23, 2005·Stroke; a Journal of Cerebral Circulation·Kenichi MishimaMichihiro Fujiwara
Jun 2, 2005·Pharmacology, Biochemistry, and Behavior·M P ViverosSandra E File
Jun 24, 2005·Nature·Andrea G HohmannDaniele Piomelli
Jan 13, 2006·British Journal of Pharmacology·Roger G Pertwee
Jan 18, 2006·Annual Review of Medicine·Vincenzo Di Marzo, Luciano De Petrocellis
Mar 17, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marco BortolatoDaniele Piomelli
May 2, 2006·Pharmacology, Biochemistry, and Behavior·Scott M RawlsAlan Cowan
May 5, 2006·Proceedings of the National Academy of Sciences of the United States of America·Erica J CarrierCecilia J Hillard
Jun 6, 2006·Psychopharmacology·Matthew N HillStan B Floresco
Jun 20, 2006·Behavioural Brain Research·Leonardo B M ResstelFrancisco S Guimarães
Jun 24, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kornelia KamprathCarsten T Wotjak
Jul 18, 2006·FEBS Letters·Eric Murillo-RodríguezRené Drucker-Colín
Aug 1, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Fabrício A MoreiraFrancisco S Guimarães

❮ Previous
Next ❯

Citations

Nov 16, 2011·Psychopharmacology·Maha M ElBatshD A Kendall
Jan 12, 2013·Psychopharmacology·Ravi K DasCelia J A Morgan
Mar 16, 2013·Psychopharmacology·H Valerie Curran, Trevor W Robbins
Apr 30, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Celia J A MorganH Valerie Curran
May 3, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cristina A J SternLeandro J Bertoglio
Sep 27, 2012·Translational Psychiatry·I HeitlandJ M P Baas
Aug 10, 2010·Behavioural Pharmacology·Plinio C CasarottoFrancisco S Guimarães
Oct 31, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Alline Cristina CamposFrancisco Silveira Guimarães
Jul 20, 2011·Journal of Psychopharmacology·S RuehleB Lutz
Feb 22, 2012·Journal of Psychopharmacology·Floris KlumpersJohanna M P Baas
Jun 23, 2010·Cell Communication and Signaling : CCS·Susanne A WolfGerd Kempermann
May 13, 2010·Reviews in the Neurosciences·Jelena Radulovic, Natalie C Tronson
Feb 4, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andras GaramiAndrej A Romanovsky
Sep 24, 2013·Neurobiology of Learning and Memory·Christine A RabinakK Luan Phan
Feb 5, 2014·Pharmacology, Biochemistry, and Behavior·Nicole L T MooreRaymond F Genovese
Jun 17, 2014·Pharmacology, Biochemistry, and Behavior·Hongbo WangXigeng Zheng
Feb 10, 2016·Frontiers in Behavioral Neuroscience·Ursula Stockhorst, Martin I Antov
Jan 29, 2016·Brain Research·Mohammad NasehiMohammad-Reza Zarrindast
Feb 3, 2016·Addiction Biology·Cristiane Ribeiro de Carvalho, Reinaldo Naoto Takahashi
Oct 31, 2015·Annual Review of Medicine·Samuel T WilkinsonDeepak Cyril D'Souza
Oct 1, 2015·Genes, Brain, and Behavior·T T-Y LeeF S Lee
Sep 18, 2012·Journal of Psychiatric Research·Alline Cristina CamposFrancisco Silveira Guimarães
Dec 10, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stephanie M GorkaChristine A Rabinak
Sep 20, 2011·Pharmacology & Therapeutics·Andrew J HillGary J Stephens
Jul 30, 2011·Pharmacology & Therapeutics·Antonia Serrano, Loren H Parsons
Jun 15, 2011·Neuropharmacology·Nimish Sidhpura, Loren H Parsons
Jan 25, 2011·Pharmacology, Biochemistry, and Behavior·Gary B Kaplan, Katherine A Moore
Mar 2, 2016·Translational Psychiatry·N D HartleyS Patel
Sep 5, 2009·Trends in Pharmacological Sciences·Angelo A IzzoRaphael Mechoulam
Dec 11, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M V FogaçaF S Guimarães
Jan 1, 2014·Brain Research Bulletin·Paul J FitzgeraldStephen Maren
May 7, 2013·Behavioural Brain Research·Fabricio H Do MonteReinaldo N Takahashi
Jul 17, 2012·Neuropharmacology·Christine A RabinakK Luan Phan
Dec 17, 2014·Learning & Memory·Brian E BernierMichael R Drew
Dec 3, 2011·Pharmacology, Biochemistry, and Behavior·Carmen Reyes-CabelloFrancisco Javier Pavón
Mar 31, 2015·Psychopharmacology·Alvaro Llorente-BerzalCarsten T Wotjak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Jasmeer P ChhatwalKerry J Ressler
Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Pauline LafenêtreGiovanni Marsicano
Progress in Neuro-psychopharmacology & Biological Psychiatry
Fabrício A MoreiraF S Guimarães
© 2022 Meta ULC. All rights reserved